Skip to main content
. 2018 Apr 20;7(2):e000281. doi: 10.1136/bmjoq-2017-000281

Table 1.

Complications of care were significantly reduced after implementation of the Transition of Care Team

Preintervention Postintervention P values
Age (median) 54 54 Mann-Whitney U test, p=0.133
Gender—female 700/1198 (58.4%) 696/1135 (61.3%) Two-proportion test, p=0.154
Gender—male 498/1198 (41.6%) 439/1135 (38.7%) Two-proportion test, p=0.154
Severity 1—minor 151/1198 (12.6%) 207/1135 (18.2%) χ2, p=0.002,
two-proportion test, p<0.001
Severity 2—moderate 451/1198 (37.6%) 409/1135 (36.0%) Two-proportion test, p=0.420
Severity 3—major 496/1198 (41.4%) 422/1135 (37.2%) Two-proportion test, p=0.037
Severity 4—extreme 100/1198 (8.3%) 96/1135 (8.5%) Two-proportion test, p=0.923
No severity score listed 0/1198 (0%) 1/1135 (0.1%) Two-proportion test, p=0.317
Length of stay (median) 3 Days
(4.4 days average)
3 Days
(4.0 days average)
Mann-Whitney U test, p=0.003
Complications of care 18/1198 (1.5%) 6/1135 (0.5%) Two-proportion test, p=0.018
30-Day readmission with exclusions (any APR-DRG)* 180/1107 (16.3%) 141/1058 (13.3%) Two-proportion test, p=0.054
Mortality rate with exclusions* 22/1197 (1.8%) 19/1132 (1.7%) Two-proportion test, p=0.770

Patient characteristics were measured for the Family Medicine Hospitalist service from the Crimson database 12 months before and after the intervention.

*Crimson 30-day readmission excluded Centers for Medicare and Medicaid Services (CMS) approved readmissions including chemotherapy, radiotherapy, dialysis, rehabilitation, elective admission, patients discharged against medical advice, mortalities, length of stay greater than 1 year and transfers to other acute-care facilities. All severity adjusted All Patient Refined Diagnosis Related Groups (APR-DRGs) were included in the readmission data. Mortality rate excluded cases with uncertainty of how much influence the physician had on the case including chemotherapy and radiotherapy patients, length of stay over 1 year, inpatient transfers from other acute-care facilities and hospice patients according to Crimson guidelines.